Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Hall

Showing results (121-130 of 387) with videos related to

Pageof 39
Sort By:
Molecular Biology of the Cell|April 17, 2009
Down-regulation of a manganese transporter in the face of metal toxicityLaran T Jensen, Mark C Carroll, Matthew D Hall, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 17, 2019
Identification of Activators of Human Fumarate Hydratase by Quantitative High-Throughput ScreeningHu Zhu, Olivia W Lee, Pranav Shah, et al.
Cardiovascular Journal of Africa|May 13, 2015
Strategic investments in non-communicable diseases (NCD) research in Africa: the GSK Africa NCD Open LabMatthew D Hall, Ann M Dufton, Roy M Katso, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
SLAS Technology|December 5, 2024
Notes on AEMS methods development for high throughput experimentation in drug discoveryMeghav Verma, Nate Hoxie, John Janiszewski, et al.
Radiation Oncology (London, England)|January 19, 2017
The use of dose-escalated radiation for locally advanced non-small cell lung cancer in the U.S., 2004-2013John P Christodouleas, Matthew D Hall, Marjorie A van der Pas, et al.
The British Journal of Dermatology|January 24, 2024
Mycophenolate mofetil inhibits Merkel cell carcinoma growthKhalid A Garman, Nicholas Thoreson, Jennifer Strong, et al.
ACS Pharmacology & Translational Science|December 17, 2020
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity AssayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
ACS Central Science|July 2, 2020
Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19Richard T Eastman, Jacob S Roth, Kyle R Brimacombe, et al.
Cancer Research|September 4, 2012
Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 familyLynn M Pouliot, Yu-Chi Chen, Jennifer Bai, et al.
Pageof 39

Showing results (121-130 of 387) with videos related to

Sort By:
Pageof 39
Molecular Biology of the Cell|April 17, 2009
Down-regulation of a manganese transporter in the face of metal toxicityLaran T Jensen, Mark C Carroll, Matthew D Hall, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 17, 2019
Identification of Activators of Human Fumarate Hydratase by Quantitative High-Throughput ScreeningHu Zhu, Olivia W Lee, Pranav Shah, et al.
Cardiovascular Journal of Africa|May 13, 2015
Strategic investments in non-communicable diseases (NCD) research in Africa: the GSK Africa NCD Open LabMatthew D Hall, Ann M Dufton, Roy M Katso, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
SLAS Technology|December 5, 2024
Notes on AEMS methods development for high throughput experimentation in drug discoveryMeghav Verma, Nate Hoxie, John Janiszewski, et al.
Radiation Oncology (London, England)|January 19, 2017
The use of dose-escalated radiation for locally advanced non-small cell lung cancer in the U.S., 2004-2013John P Christodouleas, Matthew D Hall, Marjorie A van der Pas, et al.
The British Journal of Dermatology|January 24, 2024
Mycophenolate mofetil inhibits Merkel cell carcinoma growthKhalid A Garman, Nicholas Thoreson, Jennifer Strong, et al.
ACS Pharmacology & Translational Science|December 17, 2020
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity AssayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
ACS Central Science|July 2, 2020
Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19Richard T Eastman, Jacob S Roth, Kyle R Brimacombe, et al.
Cancer Research|September 4, 2012
Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 familyLynn M Pouliot, Yu-Chi Chen, Jennifer Bai, et al.
Pageof 39